5 things to know about US healthcare spending compared to 10 other high-income countries
(By Morgan Haefner for Becker’s Hospital Review) Labor, supply and administrative costs are key reasons why the U.S. outpaces other
Read More
Health Care Finance
Bill Of The Month: For Toenail Fungus, A $1,500 Prescription
(By Shefali Luthra for Kaiser Health News) During Anne Soloviev’s semiannual visit to Braun Dermatology & Skin Cancer Center in
Read More340B hospitals provided $26M+ in uncompensated, unreimbursed care: 3 study findings
(By Kelly Gooch for Becker’s Hospital Review) Hospitals and health systems that participate in the 340B Drug Pricing Program play
Read MoreSome Anthem patients afraid to use ED under new policy: 6 things to know
(By Morgan Haefner for Becker’s Hospital Review) Ohio residents with Anthem insurance told The Plain Dealer they fear Anthem’s discretionary
Read MoreHSA use among employees seems to have slowed
The Employee Benefit Research Institute reports that while estimates from five different surveys on the adoption of HSA-eligible health plans and HSAs themselves
Read MoreHow health insurers game Medicare Advantage ratings to boost bonus payments
(By Ayla Ellison for Becker’s Hospital Review) Humana, UnitedHealth, Aetna, Anthem and other insurance companies that provide Medicare Advantage plans
Read MoreThree trends developing in employer benefit cost management
One of the top three priorities for employers in 2018 is benefit cost management. According to the Kaiser Family Foundation,
Read MoreCigna to buy Express Scripts for $67B: 5 things to know
(By Morgan Haefner for Becker’s Hospital Review) Cigna signed a definitive agreement to acquire Express Scripts for $67 billion in cash and
Read MoreUnitedHealth takes aim at costly ED visits with new policy: 5 things to know
(By Morgan Haefner for Becker’s Hospital Review) UnitedHealth Group’s insurance arm, UnitedHealthcare, changed its emergency department reimbursement policy for commercial
Read MoreGottlieb condemns ‘rigged payment scheme’ for biosimilar drugs
(By Ike Swetlitz for STAT) WASHINGTON — Food and Drug Administration Commissioner Scott Gottlieb said that it’s not his agency’s
Read More